Unlock instant, AI-driven research and patent intelligence for your innovation.

Bemeprost ophthalmic temperature-sensitive in-situ gel as well as preparation method and application thereof

A bimatoprost and ophthalmic technology, which is applied in the field of medicine, can solve the problems of no ophthalmic temperature-sensitive in-situ gel preparations, etc., to overcome poor spreadability, solve short residence time, and avoid eye irritation sexual effect

Pending Publication Date: 2020-09-08
JILIN UNIV FIRST HOSPITAL
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, clinical bimatoprost pharmaceutical preparations are mainly eye drops, and there is no ophthalmic temperature-sensitive in situ gel preparation, and there are no relevant literature reports on this type of preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bemeprost ophthalmic temperature-sensitive in-situ gel as well as preparation method and application thereof
  • Bemeprost ophthalmic temperature-sensitive in-situ gel as well as preparation method and application thereof
  • Bemeprost ophthalmic temperature-sensitive in-situ gel as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Formula (by mass volume percent):

[0058]

[0059] Preparation process: accurately weigh bimatoprost powder, add it into Tween 80 for ultrasonic dissolution, and then add double distilled water to prepare a bimatoprost solution with a concentration of 0.03%. Then add poloxamer 407 and poloxamer 188 into the bimatoprost solution according to the above ratio, seal it and put it in a refrigerator at 4°C for 24 hours to make it fully absorb water and swell and gradually dissolve until the solution is clear to obtain bimatoprost A thermosensitive in-situ gel for ophthalmic use.

[0060] Determination of gelation temperature: take 4°C bimatoprost thermosensitive in situ gel and place it in a test tube (uniform heating, large heating area, good spatial fluidity), place the test tube in a beaker inserted into an electronic thermometer and heat it with a water bath way, at 0.5℃·min -1 Slowly raise the temperature of the water-bath beaker at a rate of 10 s, and tilt the tes...

Embodiment 2

[0064] Formula (by mass volume percent):

[0065]

[0066] Preparation process: accurately weigh bimatoprost powder, add it into Tween 80 for ultrasonic dissolution, and then add double distilled water to prepare a bimatoprost solution with a concentration of 0.03%. Then add poloxamer 407 and poloxamer 188 into the bimatoprost solution according to the above ratio, seal it and put it in a refrigerator at 4°C for 24 hours to make it fully absorb water and swell and gradually dissolve until the solution is clear to obtain bimatoprost A thermosensitive in-situ gel for ophthalmic use.

[0067] The determination of the gelation temperature was the same as in Example 1. The gelation temperature of the bimatoprost ophthalmic thermosensitive in-situ gel prepared in this example was about 32.16±0.127°C before dilution with artificial tears, and the gelation temperature after dilution with artificial tears The condensation temperature is about 37.54±0.366°C.

Embodiment 3

[0069] Formula (by mass volume percent):

[0070]

[0071]

[0072] Preparation process: accurately weigh bimatoprost powder, add it into Tween 80 for ultrasonic dissolution, and then add double distilled water to prepare a bimatoprost solution with a concentration of 0.03%. Then poloxamer 407 and poloxamer 188 were added to the bimatoprost solution according to the above ratio, sealed and placed in a refrigerator at 4°C for 24 hours to allow it to fully absorb water and swell and gradually dissolve until the solution was clear to obtain bimatoprost A thermosensitive in-situ gel for ophthalmic use.

[0073] The determination of the gelation temperature was the same as in Example 1. The gelation temperature of the bimatoprost ophthalmic thermosensitive in-situ gel prepared in this example was about 31.15±0.375°C before dilution with artificial tears, and the gelation temperature after dilution with artificial tears The condensation temperature is about 37.12±0.311°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a bemeprost ophthalmic temperature-sensitive in-situ gel as well as a preparation method and an application thereof. The bemeprost ophthalmic composition is prepared from bemeprost, poloxamer, a cosolvent and water, wherein the poloxamer comprises poloxamer 407 and poloxamer 188. The composition is an ophthalmic preparation suitable for primary open-angle glaucoma and ocular hypertension with relatively high incidence rate. The composition disclosed by the invention is liquid at normal temperature, forms a semi-solid gel state after being dripped into eyes, is adhered to the surfaces of corneas and conjunctival sac and delays drug release, so that the problems of short eye retention time and low bioavailability of conventional eye drops can be solved, and the problems of poor spreadability and difficulty in dosage control of a common ophthalmic gel preparation are also solved; and meanwhile, eye irritation caused by dosage forms such as cream can be avoided, andthe gel is the ophthalmic preparation for treatment of glaucoma and having great economic benefits and development potential.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a bimatoprost ophthalmic temperature-sensitive in-situ gel and a preparation method and application thereof. Background technique [0002] Bimatoprost (English name: Bimatoprost; chemical name: (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy- 5-Phenyl-1-pentenyl]cyclopentyl]-5-N-ethylheptenamide) is a unique drug that is a synthetic prostamide that selectively mimics the naturally occurring The role of prostamide, it has a dual antihypertensive mechanism, can reduce intraocular pressure by increasing the outflow of aqueous humor through the trabecular meshwork and grape sclera. Bimatoprost is an analogue of a prostaglandin fatty acid amide developed by Allergan Company. It was first listed in the United States in March 2001. It is clinically used for the treatment of glaucoma and has a good effect and safety in lowering intraocular pressure. [0003] At present, bima...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/5575A61K47/10A61P27/06
CPCA61K9/06A61K9/0048A61K31/5575A61K47/10A61P27/06
Inventor 张四喜刘玲玲孙敬蒙闫荟羽曲晓宇
Owner JILIN UNIV FIRST HOSPITAL